Filing Details
- Accession Number:
- 0001181431-10-021899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-16 13:00:00
- Reporting Period:
- 2010-04-14
- Filing Date:
- 2010-04-16
- Accepted Time:
- 2010-04-16 17:01:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Biosciences Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1343543 | D Philip Gregory | C/O Sangamo Biosciences Inc., Ste A-100 Point Richmond Tech Cntr, 501 Canal Blvd Richmond CA 94804 | Cso & Vice President, Research | No | Yes | No | No |
Transaction Summary
| Sold: | 2,500 shares | Avg. Price: $6.15 | Total Value: $15,370.00 |
| Number of Shares After Transactions: | 17,433 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-04-14 | 500 | $6.12 | 19,433 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-14 | 1,000 | $6.14 | 18,433 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-14 | 1,000 | $6.17 | 17,433 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 8, 2010.
Billionaire Hedge Funds
